The DNA Binding Activity of Metal Response Element-binding Transcription Factor-1 Is Activated in Vivo and in Vitro by Zinc, but Not by Other Transition Metals*

Doug BittelDagger , Tim Dalton§, Susan L.-A Samsonpar , Lashitew Gedamu, and Glen K. Andrews**

From the Department of Biochemistry and Molecular Biology, University of Kansas Medical Center, Kansas City, Kansas 66160-7421 and the  Department of Biological Sciences, University of Calgary, Calgary, Alberta T2N 1N4, Canada

    ABSTRACT
Top
Abstract
Introduction
Procedures
Results
Discussion
References

We examined the DNA binding activity of mouse and human MTF-1 in whole cell extracts from cells cultured in medium containing zinc or cadmium and from untreated cells after the in vitro addition of zinc or cadmium, as well as using recombinant MTF-1 transcribed and translated in vitro and treated with various transition metals. Incubation of human (HeLa) or mouse (Hepa) cells in medium containing cadmium (5-15 µM) did not lead to a significant increase (<2-fold) in the amount of MTF-1 DNA binding activity, whereas zinc (100 µM) led to a 6-15-fold increase within 1 h. MTF-1 binding activity was low, but detectable, in control whole cell extracts and was increased (>10-fold) after the in vitro addition of zinc (30 µM) and incubation at 37 °C for 15 min. In contrast, addition of cadmium (6 or 60 µM) did not activate MTF-1 binding activity. Recombinant mouse and human MTF-1 were also dependent on exogenous zinc for DNA binding activity. Cadmium did not facilitate activation of recombinant MTF-1, but instead inhibited the activation of the recombinant protein by zinc. Interestingly, glutathione (1 mM) protected recombinant MTF-1 from inactivation by cadmium, and allowed for activation by zinc. It was also noted that zinc-activated recombinant MTF-1 was protected from cadmium only when bound to DNA. These results suggest that cadmium interacts with the zinc fingers of MTF-1 and forms an inactive complex. Of the several transition metals (zinc, cadmium, nickel, silver, copper, and cobalt) examined, only zinc facilitated activation of the DNA binding activity of recombinant MTF-1. These data suggest that transition metals, other than zinc, that activate MT gene expression may do so by mechanisms independent of an increase in the DNA binding activity of MTF-1.

    INTRODUCTION
Top
Abstract
Introduction
Procedures
Results
Discussion
References

Metallothioneins (MT)1 constitute a conserved family of cysteine-rich heavy metal-binding proteins (1). In the mouse, MT-I and MT-II display a wide tissue distribution and have been demonstrated to participate in detoxification of transition metals such as cadmium (2, 3), zinc homeostasis (4), and protection against oxidative stress (5). MT-I and MT-II gene transcription is induced dramatically by heavy metals (especially zinc and cadmium) (6). Metal response elements (MRE) are essential for this induction, and these elements are present in multiple copies in the proximal promoters of MT genes. MREs were initially shown to mediate transcriptional response of MT genes to zinc and cadmium (7-9), and more recently to oxidative stress (10, 11).

A protein that binds specifically to MREs and that transactivates MT gene expression has been cloned from mouse and human, and is termed MTF-1 (MRE-binding transcription factor-1) (12, 13). MTF-1 is a zinc finger transcription factor in the Cys2His2 family. The DNA binding activity of MTF-1 is reversibly regulated by zinc interactions with the zinc finger domain (14). In contrast with some zinc finger proteins, including zinc finger transcription factors, which can bind zinc with picomolar to nanomolar disassociation constants (15, 16), MTF-1 is regulated by micromolar concentrations of this metal. Thus, MTF-1 may serve as a sensor for "free" zinc within the cell. Manipulation of MTF-1 expression by targeted deletion of both genes in embryonic stem cells (17) or by expression of antisense MTF-1 (18) eliminates metal responsiveness of transfected MRE-driven reporter genes. Thus, MTF-1 is thought to be essential for activation of MRE activity by all of the transition metals that have been examined.

Although MTF-1 may play a role in activating MT gene expression in response to several transition metals, the nature of the interaction between MTF-1 and metals other than zinc has not been examined. To clarify the mechanisms of activation of MTF-1 by transition metals, we examined the DNA binding activity of MTF-1 in vivo in cells treated with cadmium, and we utilized whole cell extracts prepared from mouse and human cells and recombinant mouse and human MTF-1, transcribed and translated in vitro, to study effects of transition metals on MTF-1 DNA binding activity. We found that MTF-1 DNA binding activity is poorly activated in vivo by cadmium, and that it is activated in vitro by zinc but not by any of the other transition metals tested. These data suggest that transition metals, other than zinc, activate MT gene expression through mechanisms independent of a significant increase in DNA binding activity of MTF-1.

    EXPERIMENTAL PROCEDURES
Top
Abstract
Introduction
Procedures
Results
Discussion
References

Cell Culture-- Mouse Hepa cells were maintained in Dulbecco's modified Eagle's medium-high glucose supplemented with 2% fetal bovine serum. HeLa cells were maintained in RPMI 1640 medium with 10% fetal bovine serum, 100 units/ml penicillin, and 50 µg/ml streptomycin, and canine Madin-Darby kidney cells (American Type Culture Collection, Rockville, MD) were cultured in Dulbecco's modified Eagle's medium-high glucose supplemented with 10% fetal bovine serum.

Preparation of Whole Cell Extracts-- Whole cell extracts were prepared as described previously (19), with modifications (14). Cells were lysed by suspension in 3 volumes of extraction buffer (20 mM HEPES (pH 7.9), 1.5 mM MgCl2, 400 mM KCl, 0.5 mM DTT, 0.2 mM phenylmethylsulfonyl fluoride, and 25% glycerol) and centrifuged at 89,000 × g for 5 min. The supernatant was collected and stored in aliquots at -80 °C. Protein concentrations were determined using a Bradford protein assay (Bio-Rad) using rabbit IgG as a standard.

In Vitro Transcription/Translation of Mouse and Human Recombinant MTF-1-- The mouse MTF-1 cDNA clone was described previously (14), whereas that for human MTF-1 was a generous gift from Dr. Walter Schaffner, University of Zurich, Switzerland. Human MTF-1 cDNA was amplified by polymerase chain reaction using flanking primers and subcloned into the XbaI site of the pcDNA3 plasmid (Invitrogen Corp., Palo Alto, CA). Recombinant MTF-1 was synthesized in vitro using a TnT Coupled Reticulocyte Lysate Transcription/Translation System (Promega Biotech), containing 1 µg of the MTF-1 plasmid and Sp6 (mouse MTF-1) or T7 (human MTF-1) RNA polymerase according to the manufacturers' suggestions.

Electrophoretic Mobility Shift Assay-- EMSA was performed as described (11, 14). Proteins from whole cell extracts (20 µg) or the MTF-1 in vitro transcription/translation reaction (1 µl of a 50-µl reaction) were incubated in buffer containing 12 mM HEPES (pH 7.9), 60 mM KCl, 0.5 mM DTT, 12% glycerol, 5 mM MgCl2, 0.2 µg of poly(dI·dC)/µg of protein, 2-4 fmol of end-labeled MRE-s double-stranded oligonucleotide (5000 cpm/fmol) in a total volume of 20 µl (20) as described in the figure legends and under "Results." Effects of the addition of exogenous metals on MTF-1·MRE·s complex formation were examined, as were effects of incubation temperature, time, and the concentration of reducing agent. ZnSO4, CdCl2, CoCl2, CuSO4, NiCl2, AgNO3, were dissolved in acidified H2O as 1000 times concentrated stock solutions. Glutathione (GSH) was dissolved fresh as a 20 mM solution in 50 mM Tris-HCl (pH 8.0). The oligonucleotide sequences used were as follows; bold bases denote the functional core: 5'-GATCCAGGGAGCTCTGCACACGGCCCGAAAAGTAGTCCCTCGAGACGTGTGCCGGGCTTTTCATCTAG-3' for MRE-s (12) and GATCCCGGCCCCGCCCATCCCCGGCCCCGCCCATCCAGGCCGGGGCGGGTAGGGGCCGGGGCGGGTAGGTCTAG for Sp1 (21).

Protein-DNA complexes were separated at 4 °C using 4% polyacrylamide gel (acrylamide:bisacrylamide, 80:1) electrophoresis (PAGE) at 15 V/Cm. The gel was polymerized and run in buffer consisting of 0.19 M glycine (pH 8.5), 25 mM Tris, 0.5 mM EDTA. After electrophoresis, the gel was dried and labeled complexes were detected by autoradiography.

    RESULTS
Top
Abstract
Introduction
Procedures
Results
Discussion
References

The DNA Binding Activity of Native MTF-1 Is Activated by Zinc, but Not by Cadmium Both in Vivo and in Vitro-- MTF-1 binding activity was examined in whole cell and nuclear extracts by EMSA using a consensus MRE oligonucleotide (MRE-s) that has a specific, high affinity MTF-1-binding site (12). Several lines of evidence have established that MTF-1 is a component of the complex formed with MRE-s in whole cell and nuclear extracts (11, 14). This complex is absent from embryonic stem cells lacking MTF-1 (22) and is restored after transfection with a mouse MTF-1 expression plasmid (14). The mobility shift, sequence specificity, and zinc dependence of this complex are indistinguishable from that of recombinant MTF-1.

Our previous studies documented that the DNA binding activity of MTF-1 is positively regulated both in vivo and in vitro by zinc. In contrast, the effects of other transition metals on the DNA binding activity of MTF-1 have not been examined. A modest activation (<2-fold) of MTF-1 binding activity was detected in whole cell extracts from Hepa cells incubated in medium containing 6 or 60 µM cadmium (14). Cadmium is a 5-10-fold more potent inducer of MT mRNA than zinc (23, 24), and 6 µM cadmium dramatically induced MT-I mRNA in these cells (data not shown), as does 60 µM zinc (10). Whole cell extracts from mouse Hepa and human HeLa cells incubated for 1 h in medium containing zinc (60 µM) or cadmium (6 µM) were analyzed for MTF-1 binding activity using EMSA (Fig. 1A). MTF-1 binding activity was low, but detectable, in untreated Hepa and HeLa cells, and increased 15- and 6-fold, respectively, after zinc treatment, but <2-fold in response to cadmium. Sp1 binding activity was unaffected by zinc or cadmium treatment of these cell lines (Fig. 1B). Furthermore, addition of zinc (30 µM) to the whole cell extracts from cadmium-treated cells resulted in a temperature dependent activation of MTF-1 binding activity, which demonstrated that MTF-1 was recovered from the cadmium-treated cells (data not shown). We also noted that zinc, but not cadmium resulted in increased MTF-1 binding activity in nuclear extracts from HeLa and Hepa cells (data not shown). Thus, zinc but not cadmium, in concentrations that dramatically activate MT gene expression, leads to a rapid increase in MTF-1 binding activity in vivo.


View larger version (68K):
[in this window]
[in a new window]
 
Fig. 1.   In vivo activation of MTF-1 DNA binding activity in mouse Hepa and human HeLa cells by zinc, but not by cadmium. Whole cell extracts were prepared from mouse Hepa cells and human HeLa cells that had been incubated for 1 or 4 h, as indicated, in medium containing 60 µM zinc or 6 µM cadmium. Aliquots of whole cell extracts (20 µg of protein) were analyzed by EMSA using a labeled MRE-s oligonucleotide (part A) or a labeled Sp1 oligonucleotide (part B). Binding reactions were incubated on ice for 20 min and subjected to PAGE. Gels were dried and labeled MRE-s or Sp1 were detected by autoradiography. The specific complexes are indicated by arrows. The Sp1 oligonucleotide has two binding sites which give rise to two predominant bands during EMSA.

MTF-1 binding activity can be dramatically increased in vitro by the addition of low micromolar concentrations of zinc to whole cell extracts from control (untreated) cells (14). This activation process is time and temperature dependent and is maximal in whole cell extracts containing exogenous zinc (30 µM) after incubation at 37 °C for 15 min. The effects of cadmium on the binding activity of MTF-1 were examined using whole cell extracts from untreated Hepa, HeLa, and canine Madin-Darby kidney cells (Fig. 2A). The indicated concentrations of zinc and/or cadmium were added to the EMSA binding reactions, and the reactions were incubated at 37 °C for 15 min before addition of labeled MRE-s and subsequent electrophoresis. Under these conditions, cadmium, even at high (60 µM) concentration, had no effect on MTF-1 binding activity. In contrast, as little as 2 µM zinc caused a detectable activation of MTF-1 and 30 µM zinc resulted in a >10-fold activation. Furthermore, cadmium did not appreciably effect the ability of zinc to activate MTF-1 in vitro in these whole cell extracts discounting the possibility that cadmium irreversibly denatures MTF-1 (Fig. 2A). In vitro activation of MTF-1 by zinc is temperature sensitive, so we examined the effects of temperature on cadmium (6 µM) activation of MTF-1 binding activity (Fig. 2B). Again, cadmium failed to cause activation of MTF-1 in Hepa whole cell extracts, regardless of the incubation temperature examined (4-37 °C). Remarkably, cadmium did not reduce the constitutive Sp1 binding activity in these same whole cell extracts (Fig. 2C).


View larger version (51K):
[in this window]
[in a new window]
 
Fig. 2.   In vitro activation of MTF-1 DNA binding activity by zinc, but not by cadmium, in whole cell extracts from untreated mouse, human, and canine cells. Whole cell extracts (20 µg/reaction) from untreated mouse Hepa, human HeLa, or canine Madin-Darby kidney cells were adjusted to the indicated final concentrations of exogenous zinc, cadmium, or both. Binding reactions were incubated at 37 °C for 15 min, labeled MRE-s was added and the incubation was continued at 4 °C for 20 min (part A). The effect of temperature on activation of the DNA binding activity of MTF-1 by cadmium was examined. Binding reactions containing whole cell extract from untreated Hepa cells were adjusted to 6 µM cadmium and incubated for 15 min at the indicated temperature. Labeled MRE-s (part B) or labeled Sp1 oligonucleotide (part C) was added and the incubation continued at 4 °C for 20 min. All binding reactions were then subjected to PAGE. Gels were dried and labeled MRE-s was detected by autoradiography. Shown here is only that region of each gel containing the MTF-1·MRE-s complex (part A) or the entire gel with this complex indicated by an arrow (part B). The Sp1 complexes are indicated by arrows (part C).

The DNA Binding Activity of Recombinant MTF-1 Is Activated by Zinc, but Not by Cadmium, and Higher Concentrations of Cadmium Interfere with Zinc Activation-- The effects of zinc and cadmium on mouse and human MTF-1 binding activity were examined using recombinant MTF-1 produced in a coupled transcription/translation system (TnT lysate). As reported previously (14), mouse MTF-1 synthesized in the TnT reaction exhibits little or no DNA binding activity before the addition of exogenous zinc (30 µM) followed by incubation at 37 °C for 15 min. This was also the case for human MTF-1, and half-maximal activation of recombinant mouse and human MTF-1 required 2-3 µM zinc under these conditions (Fig. 3A). In contrast, cadmium (3 µM) did not lead to activation of MTF-1, nor did it inhibit the ability of zinc to activate this DNA binding activity (Fig. 3B, data for mouse MTF-1 are shown). However, it was noted that activation of recombinant MTF-1 by zinc (30 µM) was reduced by 60% when 6 µM cadmium was included during the activation process (37 °C for 15 min) (Fig. 3C, lane 3). Higher concentrations of cadmium (30 µM) completely prevented zinc activation of MTF-1 (Fig. 3D, lanes 4 and 5). Similar results were obtained using recombinant human MTF-1 (data not shown). The TnT lysate contains 18.8 ± 3.7 µM total zinc (14). Therefore, these EMSA reactions contained about 2 µM zinc. If cadmium had caused the redistribution of this zinc, then the MTF-1 binding activity would have been half-maximal.


View larger version (23K):
[in this window]
[in a new window]
 
Fig. 3.   In vitro activation of recombinant mouse MTF-1 DNA binding activity by zinc, and inactivation of this activity by cadmium. Recombinant mouse and human MTF-1 were synthesized in vitro in a TnT lysate programmed with mouse (14) or human (13) MTF-1 plasmid, as described (14). The DNA binding activity of MTF-1 was detected by EMSA. Part A, the effects of zinc concentration on the DNA binding activity of mouse MTF-1 (mMTF) or human MTF-1 (hMTF) were examined. Binding reactions (14 µl) were assembled with 0.5 µl of the TnT lysates and the indicated concentrations of exogenous zinc. Binding reactions were incubated at 37 °C for 15 min, placed on ice, and labeled MRE-s oligonucleotide was added. After 15 min at 4 °C, the reactions were subjected to PAGE. The amount of MTF-1·MRE-s complex was quantitated by PhosphorImage analysis. Reactions containing 30 µM zinc served as the 100% activation standards and values shown represent the average ± S.E. of three determinations. Part B, binding reactions contained labeled MRE-s oligonucleotide and, as indicated, zinc (30 µM) and/or cadmium (3 µM). Reactions were incubated at 37 °C for 15 min, and then at 4 °C for 20 min before PAGE. In the absence of exogenous zinc or if MTF-1 plasmid was omitted, no MTF-1 binding activity was detected (14). Part C, binding reactions containing recombinant mouse MTF-1 were adjusted to 30 µM zinc and incubated at 37 °C for 15 min (lanes 1-3). In lane 2, the zinc-activated MTF-1 was then allowed to bind to MRE-s, and 6 µM cadmium was subsequently added and the mixture was incubated at 37 °C for 15 min. In lane 3, 6 µM cadmium was added at the same time as zinc. In lane 4, MTF-1 was incubated with 6 µM cadmium alone. Labeled MRE-s was then added and these reactions (lanes 2-4) were incubated at 4 °C for 20 min before PAGE. The arrow indicates the specific MTF-1·MRE-s complex. The amount of complex was quantitated by PhosphorImage analysis. Part D, the effect of cadmium on pre-existing zinc-activated MTF-1 and MTF-1·MRE-s complexes was investigated. The binding reaction containing 30 µM zinc served as a comparative standard (lane 1). MTF-1 was activated with 30 µM zinc and allowed to bind to MRE-s. 60 µM cadmium (lane 2) or 30 µM cadmium (lane 4) was subsequently added and the mixture incubated at 37 °C for 15 min. In parallel samples, MTF-1 was activated with 30 µM zinc, as above, and then 60 (lane 3) or 30 (lane 5) µM cadmium was added and the mixture incubated at 37 °C for 15 min. Labeled MRE-s was added and samples were analyzed by PAGE. The arrow indicates the specific MTF-1·MRE-s complex.

Effects of cadmium on recombinant MTF-1 that had been previously activated with zinc were examined. Zinc-activated mouse MTF-1 or mouse MTF-1·MRE-s complexes were incubated with cadmium. Relative to free mouse MTF-1, pre-existing mouse MTF-1·MRE-s complexes were significantly more resistant to cadmium. Pre-existing mouse MTF-1·MRE-s complexes were resistant to 6 µM cadmium (Fig. 3C, compare lanes 2 and 3) and 30 µM cadmium (Fig. 3D, compare lanes 4 and 5). In contrast, 60 µM cadmium dramatically reduced the amount of complex detected regardless of whether the protein was bound to DNA or free (Fig. 3D, compare lanes 2 and 3). Thus, cadmium can negatively effect the ability of zinc to activate MTF-1, and can reverse the DNA binding activity of zinc-preactivated MTF-1. In contrast, DNA-bound MTF-1 is resistant to cadmium inactivation.

Glutathione Provides Protection of MTF-1 from Cadmium Interference with Zinc Activation of DNA Binding Activity-- The above results suggested that cadmium, which is highly reactive with thiols, may be interacting with cysteine residues of MTF-1, the majority of which are found in the six zinc fingers. The finding that zinc-activated MTF-1·DNA complexes are more resistant to cadmium inactivation is consistent with this notion. Interestingly, native MTF-1 in whole cell extracts was much more resistant than was recombinant MTF-1 to the effects of cadmium inhibition of zinc activation. Therefore, we examined whether the major cellular antioxidant GSH could protect MTF-1 from this effect of cadmium. GSH also binds metal ions (25), and thus might compete for or facilitate metal interactions with MTF-1. GSH when oxidized facilitates release of zinc from MT (26) and when reduced facilitates transfer of copper into MT (27). Inclusion of 1 mM GSH in the EMSA binding buffer did not interfere with zinc (30 µM) activation of recombinant MTF-1, whereas 10 mM GSH prevented zinc activation (Fig. 4A). GSH (1 mM) provided protection for MTF-1 against 6 µM cadmium and provided some protection against 30 µM cadmium (Fig. 4A). However, even in the presence of GSH, neither recombinant mouse nor human MTF-1 were activated to a DNA binding form by cadmium (Fig. 4B). Although not as effective as GSH, other reducing agents (DTT and beta -mercaptoethanol) also provided some protection against the detrimental effects of cadmium on MTF-1, and in higher concentrations (>10 mM) prevented zinc activation (data not shown).


View larger version (62K):
[in this window]
[in a new window]
 
Fig. 4.   GSH can protect mouse and human recombinant MTF-1 from cadmium inactivation of DNA binding activity. Recombinant mouse and human MTF-1 were synthesized in vitro in a TnT lysate programmed with mouse MTF-1 (14) or human MTF-1 (13) plasmid. The DNA binding activity of MTF-1 was detected by EMSA. Part A, recombinant mouse MTF-1 was examined. Binding reactions contained labeled MRE-s oligonucleotide and 30 µM zinc, plus GSH (1 or 10 mM) and/or cadmium (6 or 30 µM), as indicated. Reactions were incubated at 37 °C for 15 min, and then labeled MRE-s was added and the incubation continued at 4 °C for 20 min before PAGE. The arrow indicates the specific MTF-1·MRE-s complex. Part B, recombinant mouse MTF-1 (mMTF-1) and human MTF-1 (hMTF-1) were analyzed by EMSA using labeled MRE-s. Binding reactions were adjusted to contain zinc (30 µM), zinc plus GSH (1 mM), cadmium (6 µM) plus GSH, or zinc and cadmium plus GSH, as indicated. Reactions were incubated at 37 °C for 15 min and then at 4 °C for 20 min before PAGE. The arrow indicates the specific MTF-1·MRE-s complex.

Transition Metals Other than Zinc Do Not Activate Recombinant MTF-1-- Many transition metals have been reported to induce MT gene expression (17, 18), and it has been suggested that some of these metals may cause the redistribution of zinc, thus leading to activation of MTF-1 (18). To determine whether any of these metals can directly activate MTF-1, the effects of nickel, silver, copper, and cobalt on the DNA binding activity of recombinant MTF-1 were determined. Each metal ion was tested at several concentrations, ranging from 3 to 500 µM, in the presence or absence of 1 mM GSH. Each metal at higher concentrations inhibited the zinc activation of MTF-1. However, the effective inhibitory concentration was metal-specific, and in each case 1 mM GSH provided significant protection (see Fig. 5). Of the metals examined, cadmium, copper and nickel were inhibitory in the lowest concentrations to zinc activation of MTF-1. Using the maximal concentration of each metal ion that allowed for complete activation of MTF-1 in the presence of zinc (30 µM) and 1 mM GSH (Fig. 5), it was found that none of the metals tested caused the activation of MTF-1 binding activity.


View larger version (84K):
[in this window]
[in a new window]
 
Fig. 5.   In vitro activation of the DNA binding activity of recombinant mouse MTF-1 by zinc, but not by other transition metals. Recombinant mouse MTF-1 was synthesized in vitro in a TnT lysate programmed with mouse MTF-1 (14) plasmid. The DNA binding activity of MTF-1 was detected by EMSA using labeled MRE-s. Binding reactions all contained GSH (1 mM), and zinc (30 µM), and/or the indicated concentration of each transition metal. Reactions were incubated at 37 °C for 15 min and then labeled MRE-s was added and the incubation was continued at 4 °C for 20 min before PAGE. The arrow indicates the specific MTF-1·MRE-s complex.

    DISCUSSION
Top
Abstract
Introduction
Procedures
Results
Discussion
References

The zinc finger transcription factor MTF-1 has been suggested to play an essential role in induction of MT gene expression by several transition metals (17, 18). Among these transition metals, zinc and cadmium are the most effective inducers of MT gene expression in mouse cells. The dose-response for induction of MT genes and MRE-driven reporter genes by cadmium is 5-10-fold lower than that for zinc. We recently reported that zinc can reversibly and directly activate the DNA binding activity of mouse MTF-1 (14), and the amount of MTF-1 DNA binding activity, measured in vitro, is dramatically and rapidly increased after treatment of cells with zinc or oxidative stress-inducing agents (11). This increased MTF-1 activity correlates with increased occupancy of MREs in the MT-I promoter (11). Interestingly, the efficacy of induction by many transition metals, of MRE-driven reporter gene expression in transfected cells, is diminished when the concentration of zinc in the culture medium is reduced. Therefore, it has been suggested that zinc mediates induction of MT gene expression by other transition metals (18). Furthermore, genomic footprinting suggests that cadmium increases the occupancy of MREs in MT promoters in cultured cells (28) which implies that cadmium activates the DNA binding activity of MTF-1 in vivo. Therefore, we examined MTF-1 DNA binding activity in cells treated with zinc or cadmium, and of recombinant MTF-1 synthesized in a coupled transcription-translation system and exposed to various transition metals in vitro.

In contrast with oxidative stress and zinc (11, 14), cadmium has little effect on the amount of MTF-1 DNA binding activity extracted from Hepa cells cultured in medium containing cadmium. Furthermore, the modest increase in MTF-1 activity that we reported previously (14) was detected later than induction of MT-I gene expression by cadmium in these cells. The results reported herein confirm and extend our previous conclusion that cadmium, in concentrations that rapidly and efficiently induce MT gene expression, does not cause the rapid activation of MTF-1 DNA binding activity in mouse, human, and dog cells. These results suggest that cadmium does not simply cause the redistribution of zinc which, in turn, rapidly activates MTF-1 to bind to DNA. Our results cannot exclude the possibility that cadmium causes an increase in the binding affinity of a small amount of MTF-1. This might explain the increased occupancy of MREs detected in vivo after treatment of cultured cells with cadmium (28). Due to the difficulty in detecting the small amount of MTF-1 binding activity in the cadmium-treated cells, it was not possible to accurately compare the affinity of binding of this transcription factor in cadmium-treated versus zinc-treated cells.

Recombinant human and mouse MTF-1 synthesized in vitro in a coupled transcription-translation system is not competent to bind to DNA, but can be activated by low micromolar concentrations of zinc (2-3 µM) in a temperature-dependent manner. Examination of the ability of several transition metals, including cadmium, to activate recombinant MTF-1 in vitro revealed that none of these metal ions, other than zinc, directly activated this transcription factor to bind to DNA. The TnT lysate contributed 2 µM zinc to the EMSA reactions, which if freed would be expected to cause half-maximal activation of MTF-1. However, similar to the whole cell extracts which contained significant levels of zinc, cadmium and other transition metals did not activate MTF-1. A wide range of metal concentrations was examined in these experiments. These results are consistent with the hypothesis that transition metals that activate MT gene expression do so by indirect mechanisms independent from those used by zinc.

Unlike recombinant human and mouse MTF-1 which display no binding activity in the absence of exogenous zinc, in cultured cells about 10% of the MTF-1 extracted is active to bind to DNA in the absence of exogenous zinc (11). This constitutive activity does not result from activation during extraction since at 4 °C even high concentrations of exogenous zinc do not activate the DNA binding activity of MTF-1 (14). The presence of a basal amount of activated MTF-1 in the cell is perhaps not surprising since it has been hypothesized that maintenance of zinc homeostasis within the cell involves not only the efflux of zinc by specific transporters (29, 30), but also a balance between zinc-dependent MTF-1 activation of MT gene transcription and the synthesis of the major intracellular zinc-binding protein MT. This scenario is analogous to the control of copper homeostasis in yeast by the copper-dependent transcription factor ACE1 and the yeast MT, CUP1 (31, 32). Since all transition metals that activate mammalian MT gene expression are thought to do so via MTF-1, and with the exception of zinc, without a significant increase in MTF-1 binding activity, our data suggest that these transition metals make use of the activated MTF-1 that pre-exists in the cell to increase MT gene expression. This notion is indirectly supported by the observation that zinc concentration in the culture medium influences the extent of induction of an MRE-driven reporter gene by other transition metals, including cadmium (18). The mechanism by which transition metals other than zinc act on MTF-1 to increase MT gene expression is poorly understood.

It is possible that transition metals alter the transactivation potential of MTF-1 by releasing an inhibitor or activating a co-activator. We speculate that reversible phosphorylation of MTF-1 may play a role in modulating the activities of this transcription factor. Cadmium can stimulate myosin light chain kinase (33), affect calmodulin activity in the brain (34), and evoke inositol polyphosphate formation (35). Cadmium induction of c-myc may involve the activation of protein kinase C (36). Cadmium may modulate gene expression by interfering with normal cellular signaling mechanisms at the levels of receptors, calcium and zinc homeostasis, protein phosphorylation, and modification of transcription factors (37). Mouse MTF-1 contains a serine/threonine-rich transactivation domain (22), and several potential sites of phosphorylation, but no studies of the phosphorylation state of the protein have been reported.

The proximal promoter of the mouse MT-I gene contains a complex array of transcriptional activation elements, and although it has been shown that MTF-1 is essential for basal level expression of MT, as well as heavy metal induction (17, 18), it seems likely that MTF-1 may function in cooperation with other transcription factors to regulate MT gene expression. Therefore, induction of MT by heavy metals other than zinc may involve the enhanced interaction of other transcription factors with MTF-1 in the absence of an increase in MTF-1 DNA binding activity. It is clear that MTF-1 plays an integral role in transducing a complex cascade of signals resulting in the activation of MT gene transcription. Determining the nature of the mechanism by which heavy metals initiate this cascade requires further investigation.

Rather than activate the DNA-binding capacity of recombinant MTF-1, it was noted that, in vitro, several transition metals actually inhibited the activation of recombinant MTF-1 by zinc. Cadmium was much less efficient at inhibiting preformed MTF-1·DNA complexes than it was at inhibiting free MTF-1. We (11) and others (12) have noted that zinc-activated MTF-1 bound to MRE-s contains a proteinase-resistant DNA-binding domain. Furthermore, relative to Sp1, MTF-1 binding activity is more sensitive to EDTA, and is stabilized by DNA interactions (14). These data, and deletion mutagenesis experiments, suggest that the reversible interactions of zinc with the zinc finger domain of MTF-1 modulates its DNA binding activity. Other transition metals likely inhibit zinc binding to MTF-1 zinc fingers (16). Consistent with this notion, it was found that GSH, in physiological concentrations (1 mM), and low levels of DTT or beta -mercaptoethanol, provided protection against the detrimental effects of transition metals on zinc activation of MTF-1, whereas, higher concentrations (10 mM) of reducing agents prevented the activation of recombinant MTF-1 by zinc. Thus, the redox status of thiols in MTF-1 may be critical for zinc activation of DNA binding activity. Alternatively, or in addition, the effects of GSH may reflect its metal binding ability (25, 38). GSH binds cadmium with an equilibrium constant of 3 × 10-10 M and zinc with an equilibrium constant of 2 × 10-8 M (38). At higher concentrations (10 mM) GSH may simply chelate zinc and prevent activation of MTF-1. In lower concentrations (1 mM), GSH may preferentially bind cadmium and prevent its interactions with MTF-1. In contrast, the protective effects of DTT and beta -mercaptoethanol are unlikely to reflect their metal binding capacity. In vivo, MTF-1 may be protected from inactivation by transition metals by the reducing environment within the cell and/or by the binding of these metals by metallothionein (39).

Several transition metals (cadmium, cobalt, copper, iron, mercury, manganese, nickel, and zinc) can bind to zinc finger motifs (reviewed in Ref. 16). These motifs fold in the presence of transition metal ions but not in their absence. Metal binding constants are governed by the geometry of the binding site and by the amino acid sequence of the zinc finger (15, 40). Zinc is bound with the highest affinity of the transition metals (40). The DNA binding activity of the Cys2Cys2 zinc finger domains from the glucocorticoid receptor (41) and GAL4 (42) can be restored by cadmium and/or cobalt. In contrast, the DNA binding activity of Cys2His2 zinc finger protein TFIIIA is not restored by cobalt, nickel, or iron, but can be partially restored by manganese (43). Our studies suggest that the DNA binding activity of MTF-1 is not affected by the other transition metals examined, and that zinc binding, at least as assessed by EMSA of MTF-1 activity, is of a much lower affinity than might be predicted from studies of zinc finger peptides which bind zinc with picomolar to nanomolar binding constants (15, 16, 40, 43). Therefore, MTF-1 appears to be unique among the zinc finger transcription factors in its relatively low affinity yet high specificity for zinc activation of DNA binding activity. The factors governing metal specificity and affinity of binding to MTF-1 remain to be determined.

    ACKNOWLEDGEMENTS

We are indebted to Jim Geiser and Steve Eklund for excellent technical assistance.

    FOOTNOTES

* This work was supported in part by National Institutes of Health Grant ES05704 (to G. K. A.) and a grant from the Natural Sciences and Engineering Council (NSERC) of Canada (to L. G.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Dagger Supported in part by a National Research Service Award Postdoctoral Fellowship ES05753.

§ Supported in part by a postdoctoral fellowship award from the Marion Merrell Dow Scientific Education Partnership. Current address: Dept. of Environmental Health, University of Cincinnati Medical Center, Cincinnati, OH 45267-0056.

par Supported by an Alberta Heritage Foundation for Medical Research studentship.

** To whom correspondence should be addressed: Dept. of Biochemistry and Molecular Biology, University of Kansas Medical Center, 3901 Rainbow Blvd., Kansas City, KS 66160-7421: Tel.: 913-588-6935; Fax: 913-588-7440; E-mail: gandrews{at}kumc.edu.

1 The abbreviations used are: MT, metallothionein; MRE, metal response element; DTT, dithiothreitol; EMSA, electrophoretic mobility shift assay; PAGE, polyacrylamide gel electrophoresis.

    REFERENCES
Top
Abstract
Introduction
Procedures
Results
Discussion
References

  1. Kagi, J. H. R. (1991) Methods Enzymol. 205, 613-626[Medline] [Order article via Infotrieve]
  2. Masters, B. A., Kelly, E. J., Quaife, C. J., Brinster, R. L., Palmiter, R. D. (1994) Proc. Natl. Acad. Sci. U. S. A. 91, 584-588[Abstract]
  3. Michalska, A. E., and Choo, K. H. A. (1993) Proc. Natl. Acad. Sci. U. S. A. 90, 8088-8092[Abstract/Free Full Text]
  4. Dalton, T. P., Fu, K., Palmiter, R. D., Andrews, G. K. (1996) J. Nutr. 126, 825-833[Medline] [Order article via Infotrieve]
  5. Lazo, J. S., Kondo, Y., Dellapiazza, D., Michalska, A. E., Choo, K. H. A., Pitt, B. R. (1995) J. Biol. Chem. 270, 5506-5510[Abstract/Free Full Text]
  6. Andrews, G. K. (1990) Prog. Food Nutr. Sci. 14, 193-258[Medline] [Order article via Infotrieve]
  7. Stuart, G. W., Searle, P. F., Chen, H. Y., Brinster, R. L., Palmiter, R. D. (1984) Proc. Natl. Acad. Sci. U. S. A. 81, 7318-7322[Abstract]
  8. Samson, S. L.-A., and Gedamu, L. (1995) J. Biol. Chem. 270, 6864-6871[Abstract/Free Full Text]
  9. Foster, R., and Gedamu, L. (1991) J. Biol. Chem. 266, 9866-9875[Abstract/Free Full Text]
  10. Dalton, T. P., Palmiter, R. D., and Andrews, G. K. (1994) Nucleic Acids Res. 22, 5016-5023[Abstract]
  11. Dalton, T. P., Li, Q. W., Bittel, D., Liang, L., and Andrews, G. K. (1996) J. Biol. Chem. 271, 26233-26241[Abstract/Free Full Text]
  12. Radtke, F., Heuchel, R., Georgiev, O., Hergersberg, M., Gariglio, M., Dembic, Z., and Schaffner, W. (1993) EMBO J. 12, 1355-1362[Abstract]
  13. Brugnera, E., Georgiev, O., Radtke, F., Heuchel, R., Baker, E., Sutherland, G. R., Schaffner, W. (1994) Nucleic Acids Res. 22, 3167-3173[Abstract]
  14. Dalton, T. D., Bittel, D., and Andrews, G. K. (1997) Mol. Cell. Biol. 17, 2781-2789[Abstract]
  15. Shi, Y., Beger, R. D., and Berg, J. M. (1993) Biophys. J. 64, 749-753[Abstract]
  16. Berg, J. M. (1990) J. Biol. Chem. 265, 6513-6516[Free Full Text]
  17. Heuchel, R., Radtke, F., Georgiev, O., Stark, G., Aguet, M., and Schaffner, W. (1994) EMBO J. 13, 2870-2875[Abstract]
  18. Palmiter, R. D. (1994) Proc. Natl. Acad. Sci. U. S. A. 91, 1219-1223[Abstract]
  19. Zimarino, V., and Wu, C. (1987) Nature 327, 727-730[CrossRef][Medline] [Order article via Infotrieve]
  20. Fried, M. G. (1989) Electrophoresis 10, 366-376[Medline] [Order article via Infotrieve]
  21. Briggs, M. R., Kadonaga, J. T., Bell, S. P., Tjian, R. (1986) Science 234, 47-52[Medline] [Order article via Infotrieve]
  22. Radtke, F., Georgiev, O., Müller, H.-P., Brugnera, E., and Schaffner, W. (1995) Nucleic Acids Res. 23, 2277-2286[Abstract]
  23. Wan, M., Hunziker, P. E., and Kägi, J. H. R. (1993) Biochem. J. 292, 609-615[Medline] [Order article via Infotrieve]
  24. Yagle, M. K., and Palmiter, R. D. (1985) Mol. Cell. Biol. 5, 291-294[Medline] [Order article via Infotrieve]
  25. Ballatori, N. (1994) Adv. Pharmacol. 27, 271-298[Medline] [Order article via Infotrieve]
  26. Maret, W. (1994) Proc. Natl. Acad. Sci. U. S. A. 91, 237-241[Abstract]
  27. Da Costa Ferreira, A. M., Ciriolo, M. R., Marcocci, L., Rotilio, G. (1993) Biochem. J. 292, 673-676[Medline] [Order article via Infotrieve]
  28. Andersen, R. D., Taplitz, S. J., Oberbauer, A. M., Calame, K. L., Herschman, H. R. (1990) Nucleic Acids Res. 18, 6049-6055[Abstract]
  29. Palmiter, R. D., and Findley, S. D. (1995) EMBO J. 14, 639-649[Abstract]
  30. Palmiter, R. D., Cole, T. B., and Findley, S. D. (1996) EMBO J. 15, 1784-1791[Abstract]
  31. Dameron, C. T., Winge, D. R., George, G. N., Sansone, M., Hu, S., Hamer, D. (1991) Proc. Natl. Acad. Sci. U. S. A. 88, 6127-6131[Abstract]
  32. Jensen, L. T., Howard, W. R., Strain, J. J., Winge, D. R., Culotta, V. C. (1996) J. Biol. Chem. 271, 18514-18519[Abstract/Free Full Text]
  33. Chao, S. H., Bu, C. H., and Cheung, W. Y. (1995) Arch. Toxicol. 69, 197-203[CrossRef][Medline] [Order article via Infotrieve]
  34. Vig, P. J. S., and Nath, R. (1991) Biochem. Int. 23, 927-934[Medline] [Order article via Infotrieve]
  35. Smith, J. B., Dwyer, S. D., and Smith, L. (1989) J. Biol. Chem. 264, 7115-7118[Abstract/Free Full Text]
  36. Tang, N., and Enger, M. D. (1993) Toxicology 81, 155-164[CrossRef][Medline] [Order article via Infotrieve]
  37. Beyersmann, D., and Hechtenberg, S. (1997) Toxicol. Appl. Pharmacol. 144, 247-261[CrossRef][Medline] [Order article via Infotrieve]
  38. Chaberek, S., and Martell, A. E. (1959) Organic Sequestering Agents, Wiley and Sons Inc., New York
  39. Kagi, J. H., and Schaffer, A. (1988) Biochemistry 27, 8509-8515[Medline] [Order article via Infotrieve]
  40. Krizek, B. A., Amann, B. T., Kilfoil, V. J., Merkle, D. L., Berg, J. M. (1991) J. Am. Chem. Soc. 113, 4518-4523
  41. Pan, T., Freedman, L. P., and Coleman, J. E. (1990) Biochemistry 29, 9218-9225[Medline] [Order article via Infotrieve]
  42. Pan, T., and Coleman, J. E. (1989) Proc Natl. Acad. Sci. U. S. A. 86, 3145-3149[Abstract]
  43. Berg, J. M., and Merkle, D. L. (1989) J. Am. Chem. Soc. 111, 3759-3761


Copyright © 1998 by The American Society for Biochemistry and Molecular Biology, Inc.